Genetic variation in the C-type lectin receptor CLEC4M in type 1 von Willebrand Disease patients

PLoS One. 2018 Feb 1;13(2):e0192024. doi: 10.1371/journal.pone.0192024. eCollection 2018.

Abstract

von Willebrand factor (VWF) levels in healthy individuals and in patients with type 1 von Willebrand disease (VWD) are influenced by genetic variation in several genes, e.g. VWF, ABO, STXBP5 and CLEC4M. This study aims to screen comprehensively for CLEC4M variants and investigate their association with type 1 VWD in the Swedish population. In order to screen for CLEC4M variants, the CLEC4M gene region was re-sequenced and the polymorphic neck region was genotyped in 106 type 1 VWD patients from unrelated type 1 VWD families. Single nucleotide variants (SNV) and variable number tandem repeat (VNTR) allele and genotype frequencies were then compared with 294 individuals from the 1000Genomes project and 436 Swedish control individuals. Re-sequencing identified a total of 42 SNVs. Rare variants showed no accumulation in type 1 VWD patients and are not thought to contribute substantially to type 1 VWD. The only missense mutation (rs2277998, NP_001138379.1:p.Asp224Asn) had a higher frequency in type 1 VWD patients than in controls (4.9%). The VNTR genotypes 57 and 67 were observed at higher frequencies than expected in type 1 VWD patients (6.4% and 6.2%) and showed an increase in patients compared with controls (7.4% and 3.1%). Strong linkage disequilibrium in the CLEC4M region makes it difficult to distinguish between the effect of the missense mutation and the VNTR genotypes. In conclusion, heterozygous VNTR genotypes 57 and 67 of CLEC4M were highly enriched and are the most likely mechanism through which CLEC4M contributes to disease in the Swedish type 1 VWD population.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Cell Adhesion Molecules / genetics*
  • Child
  • Child, Preschool
  • Female
  • Genetic Variation*
  • Genotype
  • Humans
  • Infant
  • Lectins, C-Type / genetics*
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide
  • Receptors, Cell Surface / genetics*
  • Sweden
  • Young Adult
  • von Willebrand Disease, Type 1 / genetics*

Substances

  • CLEC4M protein, human
  • Cell Adhesion Molecules
  • Lectins, C-Type
  • Receptors, Cell Surface

Grants and funding

Stefan Lethagen [SL] is employed by and receive salary from Sobi. The funder provided support in the form of salary for author [SL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of the author is articulated in the ‘author contributions’ section.